Jeroen Allebrandi
Associate
Jeroen advises on a wide range of corporate matters, varying from public takeovers and corporate governance to IPOs and private transactions.
Expertise
Experience
Representative matters
Koninklijke DSM on the EUR 25bn cross-border merger with Firmenich International (2022/2023).
Teslin on the EUR 1.560bn acquisition of Accell Group through a consortium with KKR (2022/2023).
Atrium European Real Estate on the EUR 565mn takeover by Gazit-Globe (2021).
Kiadis Pharma on the EUR 308mn takeover by Sanofi (2020/2021).
Wolters Kluwer and a multinational media conglomerate on the sale of their carved-out legal information-based businesses in Spain, France and Portugal for EUR 160mn to Karnov (2021/2022).
Published Work
- C.J.C. de Brauw, O. Valk, J.P. Allebrandi, R. de Groot, K. Doeve (2023), “Trends in Dutch Public M&A 2023”, Amsterdam.
- C.J.C. de Brauw, O. Valk, “Kroniek Openbare Biedingen 2015-2021”, Amsterdam: Tijdschrift Ondernemingsrechtpraktijk (TOP 2021/481 and TOP 2021/435).
- C.J.C. de Brauw, O. Valk, J.P. Allebrandi, R. de Groot (2023), “Trends in Dutch Public M&A 2022”, Amsterdam.
- C.J.C. de Brauw, O. Valk, J.P. Allebrandi, R. de Groot (2023), “Trends in Dutch Public M&A 2021”, Amsterdam.
Qualifications
Admissions
The Netherlands, 2018
Listed in the register of legal practice areas of the Dutch Bar Association for Corporate Law and M&A (Ondernemingsrecht).
Academic
LLM, Corporate Law, Vrije Universiteit Amsterdam and Universiteit van Amsterdam, 2017